oder lizenzen
letzte spalte geschätzter markteintritt, vorletzte zahl patente (laufzeit)
aus first berlin
Remimazolam PS EU €110.5M 15,144K €14 €208.6M 25% €69.9M 60% 15% 12 1 Year Remimazolam PS US €119.0M 20,000K €20 €400.0M 40% €206.0M 20% 15% 11 1 Year Remimazolam PS CAN €5.9M 1,056K €20 €21.1M 50% €13.6M 18% 15% 10 2 Years Remimazolam GA EU €181.6M 15,144K €40 €605.8M 20% €162.3M 60% 15% 11 2 Years Remimazolam GA US €71.8M 23,925K €40 €957.0M 20% €246.5M 20% 15% 8 4 Years Remimazolam GA JAP €93.3M 10,000K €40 €400.0M 25% €134.0M 18% 12% 13 - Remimazolam GA CHN €15.8M 51,000K €28 €1,405.0M 10% €188.2M 10% 15% 15 4 Years Remimazolam PS CHN €15.0M 33,260K €10 €346.5M 10% €46.4M 10% 15% 15 1 Year Remimazolam GA KOR €7.6M 3,750K €28 €103.3M 25% €34.6M 10% 15% 15 1 Year Remimazolam GA CIS/MENA/TUR €48.2M 55,247K €28 €1,566.6M 10% €209.9M 12% 15% 15 2 Years Remimazolam ICU US €16.1M 1,561K €250 €390.2M 25% €125.6M 20% 15% 7 5 Years Remimazolam ICU EU €66.5M 2,439K €167 €406.5M 25% €136.8M 60% 15% 8 4 Years Remimazolam ICU Japan €4.3M 606K €167 €101.0M 25% €33.8M 18% 15% 9 5 Years
|